These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 19549741

  • 1. Bone mineral density, prevalence of vertebral fractures, and bone quality in patients with adrenal incidentalomas with and without subclinical hypercortisolism: an Italian multicenter study.
    Chiodini I, Morelli V, Masserini B, Salcuni AS, Eller-Vainicher C, Viti R, Coletti F, Guglielmi G, Battista C, Carnevale V, Iorio L, Beck-Peccoz P, Arosio M, Ambrosi B, Scillitani A.
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3207-14. PubMed ID: 19549741
    [Abstract] [Full Text] [Related]

  • 2. Eugonadal male patients with adrenal incidentalomas and subclinical hypercortisolism have increased rate of vertebral fractures.
    Chiodini I, Viti R, Coletti F, Guglielmi G, Battista C, Ermetici F, Morelli V, Salcuni A, Carnevale V, Urbano F, Muscarella S, Ambrosi B, Arosio M, Beck-Peccoz P, Scillitani A.
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):208-13. PubMed ID: 18547342
    [Abstract] [Full Text] [Related]

  • 3. Risk of new vertebral fractures in patients with adrenal incidentaloma with and without subclinical hypercortisolism: a multicenter longitudinal study.
    Morelli V, Eller-Vainicher C, Salcuni AS, Coletti F, Iorio L, Muscogiuri G, Della Casa S, Arosio M, Ambrosi B, Beck-Peccoz P, Chiodini I.
    J Bone Miner Res; 2011 Aug; 26(8):1816-21. PubMed ID: 21472775
    [Abstract] [Full Text] [Related]

  • 4. Bone quality, as measured by trabecular bone score in patients with adrenal incidentalomas with and without subclinical hypercortisolism.
    Eller-Vainicher C, Morelli V, Ulivieri FM, Palmieri S, Zhukouskaya VV, Cairoli E, Pino R, Naccarato A, Scillitani A, Beck-Peccoz P, Chiodini I.
    J Bone Miner Res; 2012 Oct; 27(10):2223-30. PubMed ID: 22549969
    [Abstract] [Full Text] [Related]

  • 5. Bilateral and unilateral adrenal incidentalomas: biochemical and clinical characteristics.
    Morelli V, Palmieri S, Salcuni AS, Eller-Vainicher C, Cairoli E, Zhukouskaya V, Scillitani A, Beck-Peccoz P, Chiodini I.
    Eur J Endocrinol; 2013 Feb; 168(2):235-41. PubMed ID: 23169694
    [Abstract] [Full Text] [Related]

  • 6. Adrenalectomy reduces the risk of vertebral fractures in patients with monolateral adrenal incidentalomas and subclinical hypercortisolism.
    Salcuni AS, Morelli V, Eller Vainicher C, Palmieri S, Cairoli E, Spada A, Scillitani A, Chiodini I.
    Eur J Endocrinol; 2016 Mar; 174(3):261-9. PubMed ID: 26630908
    [Abstract] [Full Text] [Related]

  • 7. Effects of sex steroids on bone in women with subclinical or overt endogenous hypercortisolism.
    Tauchmanovà L, Pivonello R, De Martino MC, Rusciano A, De Leo M, Ruosi C, Mainolfi C, Lombardi G, Salvatore M, Colao A.
    Eur J Endocrinol; 2007 Sep; 157(3):359-66. PubMed ID: 17766720
    [Abstract] [Full Text] [Related]

  • 8. Beneficial metabolic effects of prompt surgical treatment in patients with an adrenal incidentaloma causing biochemical hypercortisolism.
    Chiodini I, Morelli V, Salcuni AS, Eller-Vainicher C, Torlontano M, Coletti F, Iorio L, Cuttitta A, Ambrosio A, Vicentini L, Pellegrini F, Copetti M, Beck-Peccoz P, Arosio M, Ambrosi B, Trischitta V, Scillitani A.
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2736-45. PubMed ID: 20375210
    [Abstract] [Full Text] [Related]

  • 9. Fracture risk and bone health in adrenal adenomas with mild autonomous cortisol secretion/subclinical hypercortisolism: a systematic review, meta-analysis and meta-regression.
    Pal R, Banerjee M, Prasad TN, Walia R, Bhadada T, Singh J, Bhadada SK.
    J Bone Miner Res; 2024 Aug 05; 39(7):885-897. PubMed ID: 38703381
    [Abstract] [Full Text] [Related]

  • 10. Spinal volumetric bone mineral density and vertebral fractures in female patients with adrenal incidentalomas: the effects of subclinical hypercortisolism and gonadal status.
    Chiodini I, Guglielmi G, Battista C, Carnevale V, Torlontano M, Cammisa M, Trischitta V, Scillitani A.
    J Clin Endocrinol Metab; 2004 May 05; 89(5):2237-41. PubMed ID: 15126547
    [Abstract] [Full Text] [Related]

  • 11. Does subclinical hypercortisolism adversely affect the bone mineral density of patients with adrenal incidentalomas?
    Hadjidakis D, Tsagarakis S, Roboti C, Sfakianakis M, Iconomidou V, Raptis SA, Thalassinos N.
    Clin Endocrinol (Oxf); 2003 Jan 05; 58(1):72-7. PubMed ID: 12519415
    [Abstract] [Full Text] [Related]

  • 12. Prediction of Vertebral Fractures in Patients With Monolateral Adrenal Incidentalomas.
    Morelli V, Eller-Vainicher C, Palmieri S, Cairoli E, Salcuni AS, Scillitani A, Carnevale V, Corbetta S, Arosio M, Della Casa S, Muscogiuri G, Spada A, Chiodini I.
    J Clin Endocrinol Metab; 2016 Jul 05; 101(7):2768-75. PubMed ID: 27144939
    [Abstract] [Full Text] [Related]

  • 13. The effects of cortisol and adrenal androgen on bone mass in Asians with and without subclinical hypercortisolism.
    Ahn SH, Kim JH, Cho YY, Suh S, Kim BJ, Hong S, Lee SH, Koh JM, Song KH.
    Osteoporos Int; 2019 May 05; 30(5):1059-1069. PubMed ID: 30719548
    [Abstract] [Full Text] [Related]

  • 14. Bone demineralization and vertebral fractures in endogenous cortisol excess: role of disease etiology and gonadal status.
    Tauchmanovà L, Pivonello R, Di Somma C, Rossi R, De Martino MC, Camera L, Klain M, Salvatore M, Lombardi G, Colao A.
    J Clin Endocrinol Metab; 2006 May 05; 91(5):1779-84. PubMed ID: 16522701
    [Abstract] [Full Text] [Related]

  • 15. Subclinical hypercortisol-assessment of bone fragility: experience of single osteoporosis center in Sicily.
    Lasco A, Catalano A, Pilato A, Basile G, Mallamace A, Atteritano M.
    Eur Rev Med Pharmacol Sci; 2014 May 05; 18(3):352-8. PubMed ID: 24563434
    [Abstract] [Full Text] [Related]

  • 16. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients.
    Chiodini I, Torlontano M, Scillitani A, Arosio M, Bacci S, Di Lembo S, Epaminonda P, Augello G, Enrini R, Ambrosi B, Adda G, Trischitta V.
    Eur J Endocrinol; 2005 Dec 05; 153(6):837-44. PubMed ID: 16322389
    [Abstract] [Full Text] [Related]

  • 17. In postmenopausal female subjects with type 2 diabetes mellitus, vertebral fractures are independently associated with cortisol secretion and sensitivity.
    Zhukouskaya VV, Eller-Vainicher C, Gaudio A, Cairoli E, Ulivieri FM, Palmieri S, Morelli V, Orsi E, Masserini B, Barbieri AM, Polledri E, Fustinoni S, Spada A, Fiore CE, Chiodini I.
    J Clin Endocrinol Metab; 2015 Apr 05; 100(4):1417-25. PubMed ID: 25590217
    [Abstract] [Full Text] [Related]

  • 18. Assessment of radiological vertebral fractures in HIV-infected patients: clinical implications and predictive factors.
    Gazzola L, Savoldi A, Bai F, Magenta A, Dziubak M, Pietrogrande L, Tagliabue L, Del Sole A, Bini T, Marchetti G, d'Arminio Monforte A.
    HIV Med; 2015 Oct 05; 16(9):563-71. PubMed ID: 25944496
    [Abstract] [Full Text] [Related]

  • 19. Bone mineral density and vertebral fractures in men.
    Legrand E, Chappard D, Pascaretti C, Duquenne M, Rondeau C, Simon Y, Rohmer V, Basle MF, Audran M.
    Osteoporos Int; 1999 Oct 05; 10(4):265-70. PubMed ID: 10692973
    [Abstract] [Full Text] [Related]

  • 20. Relationship between pretreatment bone resorption and vertebral fracture incidence in postmenopausal osteoporotic women treated with risedronate.
    Seibel MJ, Naganathan V, Barton I, Grauer A.
    J Bone Miner Res; 2004 Feb 05; 19(2):323-9. PubMed ID: 14969403
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.